T. Kadowaki et al., A SUBTYPE OF DIABETES-MELLITUS ASSOCIATED WITH A MUTATION OF MITOCHONDRIAL-DNA, The New England journal of medicine, 330(14), 1994, pp. 962-968
Background. Several families have been described in which a mutation o
f mitochondrial DNA, the substitution of guanine for adenine (A --> G)
at position 3243 of leucine transfer RNA, is associated with diabetes
mellitus and deafness. The prevalence, clinical features, and pathoph
ysiology of diabetes with this mutation are largely undefined. Methods
. We studied 55 patients with insulin-dependent diabetes mellitus (IDD
M) and a family history of diabetes (group 1), 85 patients with IDDM a
nd no family history of diabetes (group 2), 100 patients with non-insu
lin-dependent diabetes mellitus (NIDDM) and a family history of diabet
es (group 3), and 5 patients with diabetes and deafness (group 4) for
the mutation. We also studied the prevalence and characteristics of di
abetes in 39 patients with a syndrome consisting of mitochondrial myop
athy, encephalopathy, lactic acidosis, and stroke-like episodes who we
re known to have the mutation and 127 of their relatives (group 5). Re
sults. We identified 16 unrelated patients with diabetes associated wi
th the A --> G mutation: 3 patients from group 1 (6 percent), 2 patien
ts from group 3 (2 percent), 3 patients from group 4 (60 percent), and
8 patients from group 5 (21 percent). We also identified 16 additiona
l subjects who had diabetes and the mutation among 42 relatives of the
patients with diabetes and the mutation in groups 1, 2, 3, and 4 and
20 affected subjects among the 127 relatives of the patients in group
5. Diabetes cosegregated with the mutation in a fashion consistent wit
h maternal transmission, was frequently (in 61 percent of cases) assoc
iated with sensory hearing loss, and was generally accompanied by impa
ired insulin secretion. Conclusions. Diabetes mellitus associated with
the A --> G mutation at position 3243 of mitochondrial leucine transf
er RNA represents a subtype of diabetes found in both patients with ID
DM and patients with NIDDM in Japan.